Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.67% is 16% above its 5-year average of 4.01%, near the high end of its 5-year range (1.14%–5.10%).
As of the fiscal period ended Wednesday, December 31, 2025. 3.11% below its 12-month average of 4.82%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
4.67%
RETURN ON ASSETS (ROA) AVG TTM
4.82%
RETURN ON ASSETS (ROA) AVG 3Y
4.76%
RETURN ON ASSETS (ROA) AVG 5Y
4.01%
RETURN ON ASSETS (ROA) AVG 10Y
3.84%
RETURN ON ASSETS (ROA) AVG 15Y
4.87%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.11%
CURRENT VS 3Y AVG
-1.89%
CURRENT VS 5Y AVG
+16.31%
CURRENT VS 10Y AVG
+21.67%
CURRENT VS 15Y AVG
-4.08%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-5.27%
vs the sector median at left
IQVIA Holdings Inc.
Market Cap
$34.72B
Return on Assets (ROA)
4.67%
TTM Avg
4.82%
3Y Avg
4.76%
5Y Avg
4.01%
Market Cap
$36.28B
Return on Assets (ROA)
11.25%
TTM Avg
-0.12%
3Y Avg
-10.91%
5Y Avg
-15.37%
Market Cap
$32.77B
Return on Assets (ROA)
2.47%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
Market Cap
$31.59B
Return on Assets (ROA)
17.44%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
Market Cap
$31.31B
Return on Assets (ROA)
-7.94%
TTM Avg
-2.29%
3Y Avg
0.04%
5Y Avg
0.75%
Market Cap
$39.14B
Return on Assets (ROA)
10.82%
TTM Avg
10.56%
3Y Avg
11.14%
5Y Avg
10.55%
Market Cap
$28.33B
Return on Assets (ROA)
17.30%
TTM Avg
16.00%
3Y Avg
15.15%
5Y Avg
14.03%
Market Cap
$27.61B
Return on Assets (ROA)
14.03%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | $34.72B | 4.67% | 4.82% | 4.76% | 4.01% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 11.25% | -0.12% | -10.91% | -15.37% |
| Medline Inc. (MDLN)vs › | $32.77B | 2.47% | 3.17% | 1.75% | 1.75% |
| Zoetis Inc. (ZTS)vs › | $31.59B | 17.44% | 17.37% | 16.33% | 15.33% |
| Centene Corp. (CNC)vs › | $31.31B | -7.94% | -2.29% | 0.04% | 0.75% |
| Agilent Technologies, Inc. (A)vs › | $39.14B | 10.82% | 10.56% | 11.14% | 10.55% |
| Biogen Inc. (BIIB)vs › | $29.85B | 4.65% | 5.11% | 6.74% | 8.29% |
| ResMed Inc. (RMD)vs › | $28.33B | 17.30% | 16.00% | 15.15% | 14.03% |
| DexCom, Inc. (DXCM)vs › | $27.61B | 14.03% | 11.04% | 9.26% | 8.83% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 4.05% | 5.83% | 5.87% | 14.86% |
ROA
4.7%
ROE
22.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.54% |
| 2024-12-31 | 5.10% |
| 2023-12-31 | 5.09% |
| 2022-12-31 | 4.31% |
| 2021-12-31 | 3.91% |
| 2020-12-31 | 1.14% |
| 2019-12-31 | 0.82% |
| 2018-12-31 | 1.15% |
| 2017-12-31 | 5.76% |
| 2016-12-31 | 0.54% |
| 2015-12-31 | 9.86% |
| 2014-12-31 | 10.78% |
| 2013-12-31 | 7.39% |
| 2012-12-31 | 7.10% |
| 2011-12-31 | 10.41% |
| 2010-12-31 | 0.00% |
